• Company News

Merrimack pharmaceuticals inc

Major-Pharmaceuticals

MACK


Price

  • Last Close
  • $ 3.85 0 % -0.14
    Sep 21, 2022
  • Trading Volume
  • 9,300
  • 52-Week High/Low
  • $7.13 - $3.75

  • Market Cap Full
  • $ 75.7M
  • YTD
  • -2%
2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Q1 61.8% 13% -5% 80.1% -21.5% -24.5% 6% 5.1% -5.5% 0.1%
Q2 -5.9% 7% 4% -17.5% -36.7% -40.8% -35.6% 4.1% 44.7% 9.8%
Q3 -35.3% 21% 8% -21.1% 7.2% 17.3% 17.8% -31.2% 20.5% -45.2%
Q4 - -18.7% 72.3% -30.4% -26.9% -31.2% -35.8% -7.2% 28.7% 40.7%
J F M A M J J A S O N D
2022 32.5% 20.5% 1.4% -8.3% -10.7% 14.9% -14.5% -18.5% -7.2% - - -
2021 -2.5% -3.6% -3.1% 12.3% -9.9% 0.6% -12.4% -10.4% -3.8% -11% -9.1% -
    2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
    -2%-43%115%-17%-62%-63%-48%-30%112%-12%0%

Earnings

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Q1 -0.05 0.02 -0.78 -1.33 0.22 0.33 0.32 -2.70 -2.90 -21.40
Q2 -0.06 -0.09 -0.71 -1.33 0.22 0.40 0.21 -1.70 -3.10 -2.20
Q3 -0.04 -0.08 -0.05 0.3 0.40 0.23 0.38 -2.70 -3.90 -2.50
Q4 - -0.08 0.24 -0.67 0.89 0.25 0.41 -0.90 -3.30 13.30
A -0.1

Annual Returns

52 Week
High/Low

Quarterly Earnings

Annual
Earnings

Trading Volume

2019 2017
Q1 1.49668 8.2959
Q2 0.50074 -
Q3 - -
Q4 - -
A 1.99742 8.2959